Cargando…
Chronic Myeloid Leukaemia in The 21st Century
Autores principales: | Frazer, Rachel, Irvine, Alexandra E, McMullin, Mary Frances |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Ulster Medical Society
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1940291/ https://www.ncbi.nlm.nih.gov/pubmed/17288299 |
Ejemplares similares
-
Transformation of cytogenetically normal chronic myelomonocytic leukaemia to an acute myeloid leukaemia and the emergence of a novel +13,+15 double trisomy resulting in an adverse outcome
por: McGrattan, Peter, et al.
Publicado: (2007) -
Response to Imatinib therapy is inferior for e13a2 BCR-ABL1 transcript type in comparison to e14a2 transcript type in chronic myeloid leukaemia
por: Greenfield, Graeme, et al.
Publicado: (2019) -
Response to Therapy, Treatment Intolerance and Tyrosine Kinase Inhibitor Cessation Eligibility in a Real-World Cohort of Chronic Myeloid Leukaemia Patients.
por: McMullan, RR, et al.
Publicado: (2019) -
The histone deacetylase inhibitor Romidepsin induces as a cascade of differential gene expression and altered histone H3K9 marks in myeloid leukaemia cells
por: Clarke, Kathryn, et al.
Publicado: (2019) -
Paleontology in the 21st Century
por: Schweitzer, Mary H.
Publicado: (2023)